Skip to main content

Advertisement

Table 2 Characteristics of patients with or without observed initiation of BOT (categorical variables)

From: Treatment intensification using long-acting insulin –predictors of future basal insulin supported oral therapy in the DIVE registry

Covariate Total population BOT(observed) BOT(not observed) p-value
(N = 31,008) (N = 6,705) (N = 24,303)
n (%) n (%) n (%)
Gender     
 Male 16,728 (53.9) 3,698 (55.2) 13,030 (53.6) 0.026
 Female 14,280 (46.1) 3,007 (44.8) 11,273 (46.4)
Microvascular diseasesa     
 Yes 10,851 (35.0) 2,643 (39.4) 8,208 (33.8) <0.0001
 No 20,157 (65.0) 4,062 (60.6) 16,095 (66.2)
Macrovascular diseases     
 Yes 7,377 (23.8) 1,711 (25.5) 5,666 (23.3) <0.001
 No 23,631 (76.2) 4,994 (74.5) 18,637 (76.7)
Hypoglycaemia     
 Yes 86 (0.3) 36 (0.5) 50 (0.2) <0.0001
 No 30,922 (99.7) 6,669 (99.5) 24,253 (99.8)
  1. Legend: BOT basal supported oral therapy. Test for independence between groups by means of Fisher’s exact tests
  2. aPatient and/or physician reported data